These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 19864692)

  • 1. Persistence of bilayered living-cell therapy donor DNA 10 months after application: a case report.
    Serena TE; Bialas P
    Ostomy Wound Manage; 2009 Oct; 55(10):18-22. PubMed ID: 19864692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of living bilayered cell therapy (Apligraf) for heel ulcers.
    Karr J
    Adv Skin Wound Care; 2008 Jun; 21(6):270-4. PubMed ID: 18525250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers.
    Cavorsi J; Vicari F; Wirthlin DJ; Ennis W; Kirsner R; O'Connell SM; Steinberg J; Falanga V
    Wound Repair Regen; 2006; 14(2):102-9. PubMed ID: 16630097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Apligraf persistence and basement membrane restoration in donor site wounds: a pilot study.
    Hu S; Kirsner RS; Falanga V; Phillips T; Eaglstein WH
    Wound Repair Regen; 2006; 14(4):427-33. PubMed ID: 16939570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The longevity of a bilayered skin substitute after application to venous ulcers.
    Phillips TJ; Manzoor J; Rojas A; Isaacs C; Carson P; Sabolinski M; Young J; Falanga V
    Arch Dermatol; 2002 Aug; 138(8):1079-81. PubMed ID: 12164746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A renaissance for maggot therapy of wounds].
    Wolff H; Hansson C
    Lakartidningen; 1998 Oct; 95(41):4468-9. PubMed ID: 9803736
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of difficult wounds with Biobrane.
    Kirwan L
    Conn Med; 1995 Sep; 59(9):523-9. PubMed ID: 7587181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers.
    Brem H; Young J; Tomic-Canic M; Isaacs C; Ehrlich HP
    Surg Technol Int; 2003; 11():23-31. PubMed ID: 12931279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wound bed score and its correlation with healing of chronic wounds.
    Falanga V; Saap LJ; Ozonoff A
    Dermatol Ther; 2006; 19(6):383-90. PubMed ID: 17199681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durability of healing from spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a 6-month follow-up.
    Kirsner RS; Marston WA; Snyder RJ; Lee TD; Cargill DI; Zhang Y; Dickerson JE; Slade HB
    Wound Repair Regen; 2013; 21(5):682-7. PubMed ID: 23927847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical classification of bioengineered skin use and its correlation with healing of diabetic and venous ulcers.
    Saap LJ; Donohue K; Falanga V
    Dermatol Surg; 2004 Aug; 30(8):1095-100. PubMed ID: 15274699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective comparison of diabetic foot ulcer and venous stasis ulcer healing outcome between a dermal repair scaffold (PriMatrix) and a bilayered living cell therapy (Apligraf).
    Karr JC
    Adv Skin Wound Care; 2011 Mar; 24(3):119-25. PubMed ID: 21326023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: a case of pyoderma gangrenosum with intractable leg ulcers treated by allogeneic cultured dermal substitutes.
    Toyozawa S; Yamamoto Y; Nishide T; Kishioka A; Kanazawa N; Matsumoto Y; Kuroyanagi Y; Furukawa F
    Dermatol Online J; 2008 Nov; 14(11):17. PubMed ID: 19094855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous cultured keratinocytes on porcine gelatin microbeads effectively heal chronic venous leg ulcers.
    Liu JY; Hafner J; Dragieva G; Seifert B; Burg G
    Wound Repair Regen; 2004; 12(2):148-56. PubMed ID: 15086765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous fibroblasts to treat deep and complicated leg ulcers in diabetic patients.
    Cavallini M
    Wound Repair Regen; 2007; 15(1):35-8. PubMed ID: 17244317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a composite skin graft composed of cultured human keratinocytes and fibroblasts and a collagen-GAG matrix to cover full-thickness wounds on athymic mice.
    Cooper ML; Hansbrough JF
    Surgery; 1991 Feb; 109(2):198-207. PubMed ID: 1992553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell suspensions of autologous keratinocytes or autologous fibroblasts accelerate the healing of full thickness skin wounds in a diabetic porcine wound healing model.
    Velander P; Theopold C; Bleiziffer O; Bergmann J; Svensson H; Feng Y; Eriksson E
    J Surg Res; 2009 Nov; 157(1):14-20. PubMed ID: 19589541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Up-to-date methods of cell therapy in treatment of burns].
    Smirnov SV; Kiselev IV; Vasil'ev AV; Terskikh VV
    Khirurgiia (Mosk); 2003; (12):58-62. PubMed ID: 14671607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding experimental biology of skin equivalent: from laboratory to clinical use in patients with burns and chronic wounds.
    Ehrlich HP
    Am J Surg; 2004 May; 187(5A):29S-33S. PubMed ID: 15147989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cell therapy in treatment of trophic ulcers of lower extremities].
    Sedov VM; Andreev DIu; Smirnova TD; Paramonov BA; En'kina TN; Sominina AA; Kiselev OI; Suissi IuIu; Lebedev LV
    Vestn Khir Im I I Grek; 2006; 165(2):90-4. PubMed ID: 16752648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.